You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nirmatrelvir

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biological Availability Trial (Nirmatrelvir/ ritonavir, Nirmatrelvir/Ritonavir, Nirmatrelvir/ritonavir)

Not yet recruiting
  • Biological Availability
  • Nirmatrelvir/ ritonavir
  • +2 more
  • (no location specified)
Sep 14, 2022

Omicron Variant of COVID-19 Trial in Wenzhou (Nirmatrelvir/Ritonavir)

Completed
  • Omicron Variant of COVID-19
  • Wenzhou, Zhejiang, China
    Xiangao Jiang
Apr 12, 2023

Pharmacokinetics, Healthy Volunteers Trial in Brussels (Rosuvastatin, Nirmatrelvir/ritonavir)

Not yet recruiting
  • Pharmacokinetics
  • Healthy Volunteers
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
Jun 1, 2023

Cardiac Surgery Trial in Beijing (Nirmatrelvir/ritonavir, Ursodeoxycholic acid)

Recruiting
  • Cardiac Surgery
  • Beijing, Beijing, China
    Fuwai Hospital
Jan 18, 2023

Nirmatrelvir-ritonavir in Hospitalized Patients

Recruiting
  • Hospitalized Patients
  • Hangzhou, Zhejiang, China
    Changcheng Shi
Feb 26, 2023

Living With COVID-19 and Use of Medicines Nirmatrelvir-Ritonavir

Not yet recruiting
  • COVID-19
  • SoC
  • Disease description
  • (no location specified)
Oct 16, 2023

Learn About the COVID-19 Prescribed Paxlovid in Morocco

Not yet recruiting
  • COVID-19 Drug Treatment
  • (no location specified)
Aug 15, 2023

Healthcare Resource Use Among COVID-19 Patients Receiving

Not yet recruiting
  • Covid-19
  • nirmatrelvir, ritonavir
  • Riyadh, Saudi Arabia
    Saudi Arabia
Aug 25, 2023

Long COVID Trial (Nirmatrelvir, Ritonavir, Placebo)

Not yet recruiting
  • Long COVID
  • Nirmatrelvir
  • +2 more
  • (no location specified)
Dec 24, 2022

CKD Patients Treated With Nirmatrelvir-ritonavir

Recruiting
  • COVID-19
  • +2 more
  • Shatin, New Territories, Hong Kong
    Prince of Wales Hospital, Chinese University of Hong Kong
Nov 21, 2022

COVID-19 Trial (Azvudine, Nirmatrelvir-Ritonavir)

Not yet recruiting
  • COVID-19
  • (no location specified)
Jan 25, 2023

Healthy Trial in Cairo (Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose), Nirmatrelvir 150 mg + Ritonavir 100 mg

Recruiting
  • Healthy
  • Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Aug 4, 2022

Healthy Participants Trial (nirmatrelvir, ritonavir)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Jun 28, 2022

Safety Issues Trial in Shanghai (Nirmatrelvir and ritonavir stage 1, Nirmatrelvir and ritonavir stage 2)

Completed
  • Safety Issues
  • Nirmatrelvir and ritonavir stage 1
  • Nirmatrelvir and ritonavir stage 2
  • Shanghai, Shanghai, China
    Department of Nephrology, Renji Hospital, Shanghai JiaoTong Univ
Jun 12, 2022

COVID-19 Trial in United States (Nirmatrelvir, Ritonavir, Placebo for nirmatrelvir)

Not yet recruiting
  • COVID-19
  • Nirmatrelvir
  • +3 more
  • Miami, Florida
  • +2 more
Jul 21, 2022

Post-COVID-19 Syndrome, Long COVID, Long Covid19 Trial in Stockholm (Nirmatrelvir/ritonavir, Placebo/ritonavir)

Not yet recruiting
  • Post-COVID-19 Syndrome
  • +9 more
  • Stockholm, Sweden
    Karolinska Institutet
Apr 20, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial

Not yet recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • +4 more
  • Nirmatrelvir
  • +2 more
  • Cooperstown, New York
  • +10 more
Dec 11, 2022

COVID-19 Trial (PF-07321332 (nirmatrelvir)/ritonavir)

Not yet recruiting
  • COVID-19
  • PF-07321332 (nirmatrelvir)/ritonavir
  • (no location specified)
Aug 2, 2022

Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19 Trial (Nirmatrelvir/ritonavir, Placebo)

Not yet recruiting
  • Post COVID-19 Condition, Unspecified
  • +2 more
  • (no location specified)
May 9, 2023

Post-acute Sequelae of SARS-CoV-2 Infection, Long COVID Trial in Stanford (Nirmatrelvir, Placebo, Ritonavir)

Recruiting
  • Post-acute Sequelae of SARS-CoV-2 Infection
  • Long COVID
  • Nirmatrelvir
  • +2 more
  • Stanford, California
    Stanford University
Dec 12, 2022

COVID-19, Renal Insufficiency, Chronic Trial in Beijing (Nirmatrelvir/ritonavir)

Recruiting
  • COVID-19
  • Renal Insufficiency, Chronic
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Jul 6, 2023

COVID-19 Trial in Canada, Taiwan, United States (nirmatrelvir, ritonavir, for nirmatrelvir)

Recruiting
  • COVID-19
  • nirmatrelvir
  • +2 more
  • Mesa, Arizona
  • +43 more
Dec 29, 2022

COVID-19 Trial in United States (nirmatrelvir, ritonavir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +22 more
Jan 11, 2023

General Investigation for PAXLOVID PACK

Recruiting
  • SARS-CoV-2 Infection
  • nirmatrelvir / ritonavir
  • Tokyo, Japan
    Pfizer Local County
May 12, 2022

Effectiveness and Safety of New Oral Antivirals for COVID-19

Recruiting
  • COVID-19
  • Açores, Portugal
  • +5 more
Jun 12, 2023